Strainprint Technologies Ltd. is a prominent research platform focused on medical cannabis data and analytics. Founded in 2016 and based in Toronto, Ontario, the company provides valuable insights and data-driven solutions to various stakeholders in the cannabis industry.

The company offers a comprehensive data and analytics platform that supports global cannabis research, delivering advanced business intelligence and treatment guidance. Strainprint also provides a free mobile app for patients to track their cannabis use and outcomes, which plays a crucial role in collecting real-time data for research. Additionally, the Strainprint Community serves as an online forum for cannabis education and resources, fostering a supportive environment for users. The company publishes detailed reports based on extensive patient data, such as “The Canadian Medical Cannabis Experience,” which analyzes patient outcomes to offer insights into the effectiveness of different cannabis strains.

Strainprint’s services cater to a wide range of stakeholders, including producers, retailers, medical practitioners, pharmacies, and government entities, ensuring a comprehensive approach to cannabis research and application.